Zai Lab ZLAB
NASDAQ ZLAB
$26.31 -0.69 (-2.56%)
As of: Sep 4, 2026 · 2:37 PM EDT

Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026)

Zai Lab (ZLAB) posted Other Accumulated Expenses of $47.0 million for Q1 2026, down 26.18% sequentially from $63.7 million in Q4 2025, and up 27.71% YoY from $36.8 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026) Analysis & Trends

Zai Lab has reported Other Accumulated Expenses for 11 years, with the latest figure at $47.0 million in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 27.71% year-over-year to $47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.0 million (up 27.71% YoY) and the FY2025 annual result came in at $63.7 million, up 8.45% from the prior year.
  • Other Accumulated Expenses declined to $47.0 million in Q1 2026 per ZLAB's latest filing, from $63.7 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $83.0 million in Q4 2023 and troughed at $36.8 million in Q1 2025.
  • A 5-year average of $54.5 million and a median of $51.5 million in 2025 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2026: Other Accumulated Expenses dropped 29.23% in 2024, then gained 27.71% in 2026.
  • Over 5 years, Other Accumulated Expenses stood at $66.8 million in 2022, then rose by 24.18% to $83.0 million in 2023, then declined by 29.23% to $58.7 million in 2024, then gained by 8.45% to $63.7 million in 2025, then dropped by 26.18% to $47.0 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $47.0 million, $63.7 million, and $51.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Zai Lab 2.93 Bn 2.23 Bn 58.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.76 Mn
Mar 31, 2026 47.01 Mn
Dec 31, 2025 63.68 Mn
Sep 30, 2025 51.54 Mn
Jun 30, 2025 44.05 Mn
Mar 31, 2025 36.81 Mn
Dec 31, 2024 58.72 Mn
Sep 30, 2024 46.08 Mn
Jun 30, 2024 46.50 Mn
Mar 31, 2024 48.18 Mn
Dec 31, 2023 82.97 Mn
Sep 30, 2023 62.99 Mn
Jun 30, 2023 59.02 Mn
Mar 31, 2023 50.88 Mn
Dec 31, 2022 66.82 Mn
Sep 30, 2022 58.46 Mn
Jun 30, 2022 53.61 Mn
Mar 31, 2022 49.96 Mn
Dec 31, 2021 60.81 Mn
Sep 30, 2021 54.29 Mn